These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24780362)

  • 1. Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil.
    Saraceni V; Durovni B; Cavalcante SC; Cohn S; Pacheco AG; Moulton LH; Chaisson RE; Golub JE
    Braz J Infect Dis; 2014; 18(5):491-5. PubMed ID: 24780362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: the TB/HIV in Rio (THRio) Cohort.
    Saraceni V; Cohn S; Cavalcante SC; Pacheco AG; Moulton LH; Chaisson RE; Durovni B; Golub JE
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):98-101. PubMed ID: 24933097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.
    Schmaltz CA; Santoro-Lopes G; Lourenço MC; Morgado MG; Velasque Lde S; Rolla VC
    PLoS One; 2012; 7(9):e45704. PubMed ID: 23049842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
    Hung CC; Chen MY; Hsiao CF; Hsieh SM; Sheng WH; Chang SC
    AIDS; 2003 Dec; 17(18):2615-22. PubMed ID: 14685055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous HAART improves survival in children coinfected with HIV and TB.
    Pensi T; Hemal A; Banerjee T
    Trop Med Int Health; 2012 Jan; 17(1):52-8. PubMed ID: 21967134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of HIV infection on mortality in a cohort of patients treated for tuberculosis in the context of wide access to HAART, in Rio de Janeiro, Brazil.
    Schmaltz CA; Sant'Anna FM; Neves SC; Velasque Lde S; Lourenço MC; Morgado MG; Rolla VC; Lopes GS
    J Acquir Immune Defic Syndr; 2009 Dec; 52(5):623-8. PubMed ID: 19730270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil.
    Grinsztejn B; Veloso VG; Pilotto JH; Campos DP; Keruly JC; Moore RD
    J Acquir Immune Defic Syndr; 2007 Aug; 45(5):515-20. PubMed ID: 17558332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of death.
    da Silva Escada RO; Velasque L; Ribeiro SR; Cardoso SW; Marins LMS; Grinsztejn E; da Silva Lourenço MC; Grinsztejn B; Veloso VG
    BMC Infect Dis; 2017 May; 17(1):373. PubMed ID: 28558689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis.
    Velasco M; Castilla V; Sanz J; Gaspar G; Condes E; Barros C; Cervero M; Torres R; Guijarro C;
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):148-52. PubMed ID: 19131895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study.
    Durovni B; Cavalcante SC; Saraceni V; Vellozo V; Israel G; King BS; Cohn S; Efron A; Pacheco AG; Moulton LH; Chaisson RE; Golub JE
    AIDS; 2010 Nov; 24 Suppl 5(Suppl 5):S49-56. PubMed ID: 21079428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.
    Miranda A; Morgan M; Jamal L; Laserson K; Barreira D; Silva G; Santos J; Wells C; Paine P; Garrett D
    PLoS One; 2007 Sep; 2(9):e826. PubMed ID: 17786198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical treatment for TB in HIV: lessons from a cohort study of people living with HIV treated in Recife, Brazil.
    Albuquerque Mde F; Coimbra I; Batista Jd; Maruza M; Ximenes RA; Lacerda HR; Miranda-Filho DB; Santos ML; Rodrigues LC
    BMC Public Health; 2014 Mar; 14():289. PubMed ID: 24679187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study.
    Maruza M; Albuquerque MF; Braga MC; Barbosa MT; Byington R; Coimbra I; Moura LV; Batista JD; Diniz GT; Miranda-Filho DB; Lacerda HR; Rodrigues LC; Ximenes RA
    Int J Tuberc Lung Dis; 2012 May; 16(5):618-24. PubMed ID: 22410415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil.
    Saraceni V; Pacheco AG; Golub JE; Vellozo V; King BS; Cavalcante SC; Eldred L; Chaisson RE; Durovni B
    Braz J Infect Dis; 2011; 15(3):249-52. PubMed ID: 21670926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.
    Yang CH; Chen KJ; Tsai JJ; Lin YH; Cheng SH; Wang KF; Chiou HY
    BMC Infect Dis; 2014 Jun; 14():304. PubMed ID: 24897928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections.
    Dronda F; Sobrino P; Hernández-Novoa B; Caro-Murillo AM; Montero M; Iribarren JA; Sanz J; Del Mar Alonso M; Labarga P; Bernal E; Moreno S;
    Curr HIV Res; 2011 Jun; 9(4):229-36. PubMed ID: 21631429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.
    Dean GL; Edwards SG; Ives NJ; Matthews G; Fox EF; Navaratne L; Fisher M; Taylor GP; Miller R; Taylor CB; de Ruiter A; Pozniak AL
    AIDS; 2002 Jan; 16(1):75-83. PubMed ID: 11741165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?
    Breen RA; Smith CJ; Cropley I; Johnson MA; Lipman MC
    AIDS; 2005 Jul; 19(11):1201-6. PubMed ID: 15990574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients.
    Kwara A; Carter EJ; Rich JD; Flanigan TP
    AIDS Patient Care STDS; 2004 Jun; 18(6):341-7. PubMed ID: 15294084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.
    Dheda K; Lampe FC; Johnson MA; Lipman MC
    J Infect Dis; 2004 Nov; 190(9):1670-6. PubMed ID: 15478074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.